Because there may be exacerbation of glucotoxicity under conditions of hyperglycemia, treatment with inhibitors of AR and SDH may be particularly effective in patients at higher risk for adverse sequelae associated with SCI. The gene discussed is SORD; the disease is Hyperglycemia.